Exosomes Detection for the Prediction of the Efficacy and Adverse Reactions of Anlotinib in Patients With Advanced NSCLC
Clinical trial NCT05218759 · UNKNOWN
Trial details
- NCT number
- NCT05218759
- Sponsor
- Shanghai Chest Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-21
- Primary completion
- 2025-05-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.